MedPath

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

Phase 3
Terminated
Conditions
Chronic Kidney Disease
Metabolic Acidosis
Interventions
Drug: Placebo
Registration Number
NCT03710291
Lead Sponsor
Tricida, Inc.
Brief Summary

The purpose of this study is to evaluate the effect of TRC101 on the progression of chronic kidney disease (CKD) and to evaluate the safety profile of TRC101 in CKD patients with metabolic acidosis.

Detailed Description

This is a randomized, double-blind, placebo-controlled trial. Eligible subjects will be randomized in a 1:1 ratio to TRC101 or placebo. The primary endpoint of the study will be progression of renal disease, defined by time to first occurrence of any event in the composite endpoint consisting of a confirmed ≥ 40% reduction in eGFR, end-stage renal disease (ESRD), and renal death. The study will terminate when the independent blinded Clinical Endpoint Adjudication Committee has positively adjudicated the targeted number of primary efficacy endpoint events. The maximum duration of follow-up for a randomized subject is anticipated to be approximately 6 years.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1480
Inclusion Criteria
  • Estimated glomerular filtration rate (eGFR) 20 - 40 mL/min/1.73m^2.
  • Serum bicarbonate 12 - 20 mEq/L.
  • On maximum tolerated dose of ACE inhibitor and/or ARB.
Exclusion Criteria
  • Acute metabolic acidosis.
  • Anticipated dialysis or kidney transplant within 6 months.
  • Recent acute kidney injury.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo-
TRC101TRC101-
Primary Outcome Measures
NameTimeMethod
Progression of chronic kidney diseaseThrough study completion, up to approximately 6 years.

Time to first occurrence of: a confirmed ≥40% reduction in eGFR; ESRD; renal death.

Secondary Outcome Measures
NameTimeMethod
Death (all-cause), ESRD or a confirmed ≥50% reduction in eGFRThrough study completion, up to approximately 6 years.

Time to first occurrence of: death (all-cause); ESRD; a confirmed ≥50% reduction in eGFR.

Cardiovascular deathThrough study completion, up to approximately 6 years.

Time to cardiovascular death.

≥40% reduction in eGFRThrough study completion, up to approximately 6 years.

Time to first occurrence of a confirmed ≥40% reduction in eGFR.

Serum creatinineThrough study completion, up to approximately 6 years.

Time to first occurrence of a confirmed doubling of serum creatinine.

≥50% reduction in eGFRThrough study completion, up to approximately 6 years.

Time to first occurrence of a confirmed ≥50% reduction in eGFR.

Physical functioning (objective)18 months after randomization.

Repeated chair stand test.

ESRD or renal deathThrough study completion, up to approximately 6 years.

Time to ESRD or renal death.

Primary outcome measure OR cardiovascular deathThrough study completion, up to approximately 6 years.

Time to first occurrence of: a confirmed ≥40% reduction in eGFR; ESRD; renal death; cardiovascular death.

Physical functioning (subjective)18 months after randomization.

Kidney Disease Quality of Life Physical Functioning Survey.

All-cause hospitalizationThrough study completion, up to approximately 6 years.

Frequency of all-cause hospitalization.

All-cause mortalityThrough study completion, up to approximately 6 years.

Time to all-cause mortality.

Trial Locations

Locations (203)

Investigative Site 2606

🇸🇰

Košice, Slovakia

Investigative Site 2603

🇸🇰

Svidník, Slovakia

Investigative Site 4122

🇺🇸

Hollywood, Florida, United States

Investigative Site 4123

🇺🇸

Hollywood, Florida, United States

Investigative Site 4116

🇺🇸

Port Charlotte, Florida, United States

Investigative Site 4127

🇺🇸

Augusta, Georgia, United States

Investigative Site 4108

🇺🇸

Greenville, North Carolina, United States

Investigative Site 4106

🇺🇸

Kinston, North Carolina, United States

Investigative Site 3804

🇬🇧

Nottingham, United Kingdom

Investigative Site 4107

🇺🇸

New Bern, North Carolina, United States

Investigative Site 4414

🇦🇷

Córdoba, Argentina

Investigative Site 5101

🇦🇺

Gosford, Australia

Investigative Site 1213

🇧🇬

Montana, Bulgaria

Investigative Site 1210

🇧🇬

Pleven, Bulgaria

Investigative Site 1205

🇧🇬

Ruse, Bulgaria

Investigative Site 4203

🇨🇦

Brampton, Canada

Investigative Site 3205

🇫🇷

Lille, France

Investigative Site 2208

🇬🇪

Tbilisi, Georgia

Investigative Site 2211

🇬🇪

Tbilisi, Georgia

Investigative Site 2212

🇬🇪

Tbilisi, Georgia

Investigative Site 2209

🇬🇪

Tbilisi, Georgia

Investigative Site 2213

🇬🇪

Tbilisi, Georgia

Investigative Site 3905

🇮🇱

Jerusalem, Israel

Investigative Site 3716

🇪🇸

Barcelona, Spain

Investigative Site 3707

🇪🇸

Barcelona, Spain

Investigative Site 2713

🇺🇦

Kharkiv, Ukraine

Investigative Site 4148

🇺🇸

Denver, Colorado, United States

Investigative Site 4132

🇺🇸

Nashville, Tennessee, United States

Investigative Site 4104

🇺🇸

Miami, Florida, United States

Investigative Site 4408

🇦🇷

Córdoba, Argentina

Investigative Site 4136

🇺🇸

Azusa, California, United States

Investigative Site 4157

🇺🇸

Boca Raton, Florida, United States

Investigative Site 4146

🇺🇸

Bradenton, Florida, United States

Investigative Site 4102

🇺🇸

Coral Springs, Florida, United States

Investigative Site 4153

🇺🇸

Fort Lauderdale, Florida, United States

Investigative Site 4152

🇺🇸

Tampa, Florida, United States

Investigative Site 4130

🇺🇸

Miami Lakes, Florida, United States

Investigative Site 4141

🇺🇸

Greenbelt, Maryland, United States

Investigative Site 4124

🇺🇸

Bethlehem, Pennsylvania, United States

Investigative Site 1103

🇦🇱

Shkodër, Albania

Investigative Site 1101

🇦🇱

Tirana, Albania

Investigative Site 4402

🇦🇷

Buenos Aires, Argentina

Investigative Site 4410

🇦🇷

Corrientes, Argentina

Investigative Site 2803

🇦🇲

Yerevan, Armenia

Investigative Site 4405

🇦🇷

Mar Del Plata, Argentina

Investigative Site 4409

🇦🇷

San Luis, Argentina

Investigative Site 2809

🇦🇲

Yerevan, Armenia

Investigative site 2801

🇦🇲

Yerevan, Armenia

Investigative Site 2802

🇦🇲

Yerevan, Armenia

Investigative Site 2805

🇦🇲

Yerevan, Armenia

Investigative Site 3103

🇧🇪

Liège, Belgium

Investigative Site 2807

🇦🇲

Yerevan, Armenia

Investigative Site 1502

🇧🇾

Grodno, Belarus

Investigative Site 3108

🇧🇪

Liège, Belgium

Investigative Site 4518

🇧🇷

Caxias Do Sul, Brazil

Investigative Site 4516

🇧🇷

Curitiba, Brazil

Investigative Site 4504

🇧🇷

Curitiba, Brazil

Investigative Site 4517

🇧🇷

São Paulo, Brazil

Investigative Site 4507

🇧🇷

Juiz De Fora, Brazil

Investigative Site 4508

🇧🇷

São Paulo, Brazil

Investigative Site 4509

🇧🇷

São Paulo, Brazil

Investigative Site 4506

🇧🇷

São Paulo, Brazil

Investigative Site 4519

🇧🇷

São Paulo, Brazil

Investigative Site 1211

🇧🇬

Kozloduy, Bulgaria

Investigative Site 1206

🇧🇬

Sevlievo, Bulgaria

Investigative Site 1212

🇧🇬

Ruse, Bulgaria

Investigative Site 1204

🇧🇬

Sliven, Bulgaria

Investigative Site 1201

🇧🇬

Sofia, Bulgaria

Investigative Site 1208

🇧🇬

Veliko Tarnovo, Bulgaria

Investigative Site 1203

🇧🇬

Yambol, Bulgaria

Investigative Site 4202

🇨🇦

Kitchener, Canada

Investigative Site 4204

🇨🇦

Québec, Canada

Investigative Site 4201

🇨🇦

London, Canada

Investigative Site 4601

🇨🇱

Providencia, Chile

Investigative Site 4208

🇨🇦

Winnipeg, Canada

Investigative Site 4604

🇨🇱

Concepción, Chile

Investigative Site 4602

🇨🇱

Temuco, Chile

Investigative Site 4703

🇨🇴

Barranquilla, Colombia

Investigative Site 4708

🇨🇴

Barranquilla, Colombia

Investigative Site 4712

🇨🇴

Barranquilla, Colombia

Investigative Site 4705

🇨🇴

Cali, Colombia

Investigative Site 4709

🇨🇴

Zipaquirá, Colombia

Investigative Site 2201

🇬🇪

Batumi, Georgia

Investigative Site 3209

🇫🇷

Boulogne-Billancourt, France

Investigative Site 2106

🇨🇿

Sokolov, Czechia

Investigative Site 2107

🇨🇿

Znojmo, Czechia

Investigative Site 2205

🇬🇪

Tbilisi, Georgia

Investigative Site 2202

🇬🇪

Kutaisi, Georgia

Investigative Site 2207

🇬🇪

Tbilisi, Georgia

Investigative Site 2204

🇬🇪

Tbilisi, Georgia

Investigative Site 2206

🇬🇪

Tbilisi, Georgia

Investigative Site 2214

🇬🇪

Tbilisi, Georgia

Investigative Site 2210

🇬🇪

Tbilisi, Georgia

Investigative Site 6101

🇭🇰

Hong Kong, Hong Kong

Investigative Site 2312

🇭🇺

Budapest, Hungary

Investigative Site 2309

🇭🇺

Kaposvár, Hungary

Investigative Site 2311

🇭🇺

Baja, Hungary

Investigative Site 2304

🇭🇺

Budapest, Hungary

Investigative Site 2306

🇭🇺

Győr, Hungary

Investigative Site 2310

🇭🇺

Kistarcsa, Hungary

Investigative Site 2316

🇭🇺

Nagykanizsa, Hungary

Investigative Site 3913

🇮🇱

Afula, Israel

Investigative Site 3911

🇮🇱

Tel Aviv, Israel

Investigative Site 3902

🇮🇱

Ashkelon, Israel

Investigative Site 3408

🇮🇹

Genova, Italy

Investigative Site 3903

🇮🇱

Tiberias, Israel

Investigative Site 3407

🇮🇹

Messina, Italy

Investigative Site 3405

🇮🇹

Milano, Italy

Investigative Site 3406

🇮🇹

Napoli, Italy

Investigative Site 3402

🇮🇹

Pavia, Italy

Investigative Site 3409

🇮🇹

Reggio Calabria, Italy

Investigative Site 5207

🇰🇷

Ansan, Korea, Republic of

Investigative Site 5205

🇰🇷

Goyang, Korea, Republic of

Investigative Site 5218

🇰🇷

Cheonan, Korea, Republic of

Investigative Site 5203

🇰🇷

Anyang, Korea, Republic of

Investigative Site 5204

🇰🇷

Daejeon, Korea, Republic of

Investigative Site 5215

🇰🇷

Guri-si, Korea, Republic of

Investigative Site 5213

🇰🇷

Seoul, Korea, Republic of

Investigative Site 5208

🇰🇷

Seoul, Korea, Republic of

Investigative Site 6208

🇲🇾

Klang, Malaysia

Investigative Site 5212

🇰🇷

Wŏnju, Korea, Republic of

Investigative Site 6203

🇲🇾

Kota Bharu, Malaysia

Investigative Site 6202

🇲🇾

Kuala Lumpur, Malaysia

Investigative Site 6207

🇲🇾

Kota Bharu, Malaysia

Investigative Site 6205

🇲🇾

Kulim, Malaysia

Investigative Site 6204

🇲🇾

Kuantan, Malaysia

Investigative Site 6210

🇲🇾

Pulau Pinang, Malaysia

Investigative Site 6206

🇲🇾

Seri Manjung, Malaysia

Investigative Site 6201

🇲🇾

Sungai Petani, Malaysia

Investigative Site 4307

🇲🇽

Cuernavaca, Mexico

Investigative Site 4313

🇲🇽

Guadalajara, Mexico

Investigative Site 4304

🇲🇽

Guadalajara, Mexico

Investigative Site 4311

🇲🇽

Mexico City, Mexico

Investigative Site 4325

🇲🇽

Mexico City, Mexico

Investigative Site 4319

🇲🇽

Guadalajara, Mexico

Investigative Site 1412

🇷🇴

Oradea, Romania

Investigative Site 4302

🇲🇽

Mexico City, Mexico

Investigative Site 4320

🇲🇽

Monterrey, Mexico

Investigative Site 4315

🇲🇽

Morelia, Mexico

Investigative Site 4324

🇲🇽

Morelia, Mexico

Investigative Site 2510

🇷🇸

Krusevac, Serbia

Investigative Site 4316

🇲🇽

Mérida, Mexico

Investigative Site 4301

🇲🇽

Mérida, Mexico

Investigative Site 4310

🇲🇽

Veracruz, Mexico

Investigative Site 4312

🇲🇽

Zapopan, Mexico

Investigative Site 4305

🇲🇽

Xalapa, Mexico

Investigative Site 3507

🇳🇱

Alkmaar, Netherlands

Investigative Site 3505

🇳🇱

Amersfoort, Netherlands

Investigative Site 3503

🇳🇱

Groningen, Netherlands

Investigative Site 1305

🇲🇰

Shtip, North Macedonia

Investigative Site 1304

🇲🇰

Bitola, North Macedonia

Investigative Site 1301

🇲🇰

Skopje, North Macedonia

Investigative Site 1303

🇲🇰

Skopje, North Macedonia

Investigative Site 1302

🇲🇰

Struga, North Macedonia

Investigative Site 2421

🇵🇱

Kraków, Poland

Investigative Site 2414

🇵🇱

Warsaw, Poland

Investigative Site 2412

🇵🇱

Zabrze, Poland

Investigative Site 3605

🇵🇹

Vila Nova De Gaia, Portugal

Investigative Site 3603

🇵🇹

Lisboa, Portugal

Investigative Site 3607

🇵🇹

Lisboa, Portugal

Investigative Site 3604

🇵🇹

Aveiro, Portugal

Investigative Site 2505

🇷🇸

Niš, Serbia

Investigative Site 2501

🇷🇸

Belgrade, Serbia

Investigative Site 2508

🇷🇸

Kragujevac, Serbia

Investigative Site 2514

🇷🇸

Užice, Serbia

Investigative Site 2503

🇷🇸

Vršac, Serbia

Investigative Site 2511

🇷🇸

Zaječar, Serbia

Investigative Site 6401

🇸🇬

Singapore, Singapore

Investigative Site 6403

🇸🇬

Singapore, Singapore

Investigative Site 6404

🇸🇬

Singapore, Singapore

Investigative Site 2604

🇸🇰

Košice, Slovakia

Investigative Site 3706

🇪🇸

Barcelona, Spain

Investigative Site 6502

🇨🇳

Hualien City, Taiwan

Investigative Site 6501

🇨🇳

Kaohsiung, Taiwan

Investigative Site 6504

🇨🇳

New Taipei City, Taiwan

Investigative Site 6510

🇨🇳

Taichung, Taiwan

Investigative Site 6503

🇨🇳

Tainan, Taiwan

Investigative Site 6507

🇨🇳

Taichung, Taiwan

Investigative Site 6506

🇨🇳

Taichung, Taiwan

Investigative Site 6509

🇨🇳

Taipei, Taiwan

Investigative Site 6511

🇨🇳

Taipei, Taiwan

Investigative Site 2712

🇺🇦

Dnipro, Ukraine

Investigative Site 2721

🇺🇦

Kharkiv, Ukraine

Investigative Site 2714

🇺🇦

Ivano-Frankivs'k, Ukraine

Investigative Site 2717

🇺🇦

Kharkiv, Ukraine

Investigative Site 2704

🇺🇦

Kharkiv, Ukraine

Investigative Site 2707

🇺🇦

Kharkiv, Ukraine

Investigative Site 2706

🇺🇦

Kyiv, Ukraine

Investigative Site 2703

🇺🇦

Kyiv, Ukraine

Investigative Site 2709

🇺🇦

Kyiv, Ukraine

Investigative Site 2710

🇺🇦

Kyiv, Ukraine

Investigative Site 2716

🇺🇦

Kyiv, Ukraine

Investigative Site 2718

🇺🇦

Ternopil', Ukraine

Investigative Site 2705

🇺🇦

Kyiv, Ukraine

Investigative Site 2719

🇺🇦

Zaporizhzhya, Ukraine

Investigative Site 2715

🇺🇦

Zhytomyr, Ukraine

Investigative Site 3815

🇬🇧

Coventry, United Kingdom

Investigative Site 3801

🇬🇧

Swansea, United Kingdom

Investigative Site 4155

🇺🇸

Kansas City, Missouri, United States

Investigative Site 6512

🇨🇳

Changhua, Taiwan

Investigative Site 6103

🇭🇰

Hong Kong, Hong Kong

Investigative Site 6104

🇭🇰

Sha Tin, Hong Kong

Investigative Site 6105

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath